Trial ID or NCT#

NCT03305809

Status

recruiting iconRECRUITING

Purpose

A randomized placebo-controlled trial to evaluate the safety and efficacy of three doses of study drug LY3154207 treated for 12 weeks in participants with mild-to-moderate dementia associated with LBD (PDD or DLB).

Official Title

Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)

Eligibility Criteria

Ages Eligible for Study: 40 Years to 85 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Laurice Yang
Laurice Yang
Movement disorders specialist
Clinical Assistant Professor, Neurology & Neurological Sciences

Contact us to find out if this trial is right for you.

CONTACT


(650) 723-6469